Literature DB >> 6439741

Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma.

W Heagy, V E Kelley, T B Strom, K Mayer, H M Shapiro, R Mandel, R Finberg.   

Abstract

The expression of HLA-DR (a class II histocompatibility antigen) on monocytes isolated from the peripheral blood of normal individuals and patients with acquired immune deficiency syndrome (AIDS) was investigated by the use of dual fluorescent staining and cytofluorometry. In animal models the absence of class II positive monocytes is linked to a failure of T cells to respond to antigens. We now report that patients with AIDS have a paucity of HLA-DR+ monocytes. The percentage of HLA-DR+ monocytes among eight normal individuals ranged from 49.3 to 95.0%+, and only one individual had less than 50% HLA-DR+ monocytes. HLA-DR expression on monocytes from homosexual male patients with lymphadenopathy was similar to that of normal subjects (range, 58.0 to 97.4%+). In contrast, seven of nine patients with AIDS had less than 50% HLA-DR+ monocytes (range, 13.4 to 78.8%+). The in vitro incubation of monocytes from AIDS patients with cloned human interferon-gamma resulted in an increase of the expression of HLA-DR to near normal levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439741      PMCID: PMC425399          DOI: 10.1172/JCI111633

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.

Authors:  T A Gonwa; L J Picker; H V Raff; S M Goyert; J Silver; J D Stobo
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

2.  Kaposi's sarcoma: an oncologic looking glass.

Authors:  J E Groopman; M S Gottlieb
Journal:  Nature       Date:  1982-09-09       Impact factor: 49.962

3.  Cytofluorometric analysis of major histocompatibility antigens on human monocytes using monoclonal antibodies.

Authors:  G Nunez; P Stastny
Journal:  Hum Immunol       Date:  1983-01       Impact factor: 2.850

4.  The current outbreak of Kaposi's sarcoma and opportunistic infections.

Authors:  H W Haverkos; J W Curran
Journal:  CA Cancer J Clin       Date:  1982 Nov-Dec       Impact factor: 508.702

5.  Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS.

Authors:  M Essex; M F McLane; T H Lee; L Falk; C W Howe; J I Mullins; C Cabradilla; D P Francis
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

6.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.

Authors:  T Kasahara; J J Hooks; S F Dougherty; J J Oppenheim
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Direct evidence of homology between human DC-1 antigen and murine I-A molecules.

Authors:  M R Bono; J L Strominger
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

9.  Alpha and beta chains of SB and DR antigens are structurally distinct.

Authors:  C K Hurley; S Shaw; L Nadler; S Schlossman; J D Capra
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

10.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.

Authors:  J S Pober; M A Gimbrone; R S Cotran; C S Reiss; S J Burakoff; W Fiers; K A Ault
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more
  25 in total

1.  Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome.

Authors:  W Heagy; T B Strom; V E Kelley; J Collela; C Crumpacker; J M Williams; H M Shapiro; L Laubenstein; R Finberg
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

2.  A systematic study of host defense processes in badly injured patients.

Authors:  H C Polk; C D George; S R Wellhausen; K Cost; P R Davidson; M P Regan; A P Borzotta
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

3.  Peripheral blood dendritic cells in persons with AIDS and AIDS related complex: loss of high intensity class II antigen expression and function.

Authors:  L J Eales; J Farrant; M Helbert; A J Pinching
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 4.  Abnormalities of hematopoiesis in the acquired immunodeficiency syndrome.

Authors:  A Ganser
Journal:  Blut       Date:  1988-02

5.  Proceedings of the British Thoracic Society. 1988 summer meeting. 13-15 July, Newcastle upon Tyne. Abstracts.

Authors: 
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

Review 6.  Cellular immunology of HIV-infection.

Authors:  G P Spickett; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

7.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Preserved MHC class II antigen processing in monocytes from HIV-infected individuals.

Authors:  Laila Woc-Colburn; Lavinia Smultea; Lakshmi Ramachandra; David H Canaday
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

9.  Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro.

Authors:  J B Allen; N McCartney-Francis; P D Smith; G Simon; S Gartner; L M Wahl; M Popovic; S M Wahl
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

10.  Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon.

Authors:  G T Spear; D M Paulnock; R L Jordan; D M Meltzer; J A Merritt; E C Borden
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.